29 studies found for:    cholangiocarcinoma AND intrahepatic cholangiocarcinoma | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Next Generation Sequencing in Intrahepatic Cholangiocarcinoma
Condition: Intrahepatic Cholangiocarcinoma
Intervention: Other: exposure to different risk factors and molecular assessment
2 Recruiting Conventional or Unconventional Lymph Node Dissection During Resection of Intrahepatic Cholangiocarcinoma
Condition: Intrahepatic Cholangiocarcinoma
Interventions: Procedure: conventional lymph node dissection;   Procedure: unconventional lymph node dissection
3 Recruiting Prognosis of Resection and Radiotherapy in the Treatment of Intrahepatic Cholangiocarcinoma Patients
Condition: Intrahepatic Cholangiocarcinoma
Interventions: Procedure: Resection;   Radiation: Radiotherapy
4 Recruiting 90Y Transarterial Radioembolization (TARE) Plus Gemcitabine and Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma
Condition: Intrahepatic Cholangiocarcinoma
Interventions: Device: SIR-Spheres microspheres (Yttrium-90 Microspheres);   Drug: Gemcitabine;   Drug: Cisplatin
5 Recruiting TACE Plus Tegafur Versus TACE for Intrahepatic Cholangiocarcinoma After Curative Resection
Condition: Intrahepatic Cholangiocarcinoma
Interventions: Procedure: TACE+Tegafur;   Procedure: TACE
6 Not yet recruiting Liver Transplantation for Early Intrahepatic Cholangiocarcinoma
Condition: Intrahepatic Cholangiocarcinoma
Intervention: Procedure: Deceased donor Liver Transplantation
7 Not yet recruiting SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Condition: Intrahepatic Cholangiocarcinoma
Interventions: Drug: Cisplatin-gemcitabine;   Device: Radiation: SIRT + chemotherapy (cisplatin-gemcitabine)
8 Recruiting Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma
Conditions: Hepatocellular Carcinoma;   Intrahepatic Cholangiocarcinoma
Interventions: Device: Delcath Hepatic Delivery System;   Drug: Melphalan
9 Not yet recruiting A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma
Condition: Unresectable Intrahepatic Cholangiocarcinoma
Interventions: Drug: gemcitabine;   Drug: Cisplatin;   Drug: Conventional TACE (transarterial chemoembolization) with Doxorubicin/Mitomycin-C
10 Recruiting Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma
Condition: Cholangiocarcinoma
Interventions: Drug: oxaliplatin and gemcitabine;   Drug: capecitabine
11 Recruiting Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Drug: Dasatinib
12 Recruiting Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin or Carboplatin
Condition: Unresectable Intrahepatic Cholangiocarcinoma
Interventions: Device: LC or ONCOZENE Bead with Gem-Cis or Gem-Carbo;   Drug: Gem-Cis or Gem-Carbo
13 Recruiting Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)
Conditions: Intrahepatic Cholangiocarcinoma;   Peripheral Cholangiocarcinoma;   Cholangiolar Carcinoma;   Cholangiocellular Carcinoma
Interventions: Drug: Floxuridine (FUDR);   Drug: dexamethasone;   Drug: Gemcitabine;   Drug: Oxaliplatin;   Other: MRI;   Other: Research blood draws
14 Recruiting Treatment for Bile Duct Cancer in the Liver
Condition: Cholangio Carcinoma
Intervention: Drug: SIRT Yttrium-90
15 Recruiting Metformin And Chloroquine in IDH1/2-mutated Solid Tumors
Conditions: Glioma;   Cholangiocarcinoma;   Chondrosarcoma
Intervention: Drug: Metformin and chloroquine combination
16 Recruiting Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Liver Neoplasms
Interventions: Drug: Floxuridine;   Drug: Dexamethasone;   Drug: Gemcitabine;   Drug: Oxaliplatin
17 Recruiting International Registry on Cholangiocarcinoma Treatment
Condition: Cholangiocarcinoma
Intervention: Drug: Doxorubicin
18 Recruiting Radioactive Stents for Treatment of Unresectable Biliary Tract Cancer
Conditions: Intrahepatic Cholangiocarcinoma;   Cholangiocarcinoma of the Extrahepatic Bile Duct;   Ampullary Carcinoma;   Biliary Obstruction
Interventions: Device: radioactive stent;   Device: plastic stent
19 Not yet recruiting Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma
Conditions: Non-Resectable Cholangiocarcinoma;   Recurrent Cholangiocarcinoma;   Stage III Extrahepatic Bile Duct Cancer;   Stage III Intrahepatic Cholangiocarcinoma;   Stage IIIA Hilar Cholangiocarcinoma;   Stage IIIB Hilar Cholangiocarcinoma;   Stage IVA Extrahepatic Bile Duct Cancer;   Stage IVA Hilar Cholangiocarcinoma;   Stage IVA Intrahepatic Cholangiocarcinoma;   Stage IVB Extrahepatic Bile Duct Cancer;   Stage IVB Hilar Cholangiocarcinoma;   Stage IVB Intrahepatic Cholangiocarcinoma;   Unresectable Extrahepatic Bile Duct Carcinoma
Interventions: Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Ricolinostat
20 Recruiting Tremelimumab With Chemoembolization or Ablation for Liver Cancer
Conditions: Liver Cell Caricinoma;   Liver Cancer;   Hepatocellular Carcinoma;   Liver Neoplasms
Interventions: Drug: Tremelimumab;   Procedure: TACE;   Procedure: Radiofrequency Ablation (RFA);   Radiation: SBRT;   Procedure: Cryoablation

   Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.